Tobacco product use amongst middle and highschool students has fallen to its lowest level in 25 years, the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration announced Thursday.

The CDC and FDA collected data on youth tobacco product use through the National Youth Tobacco Survey. It found that 2.25 million middle and highschool students reported using tobacco products previously 30 days, up from 2.8 million in 2023.

The decline reflected a decline within the number of scholars who reported using electronic cigarettes, from 2.13 million in 2023 to 1.63 million in 2024.

“We are on the right track when it comes to reducing tobacco use among our nation’s youth,” Brian King, director of the FDA’s Center for Tobacco Products, said in a news release Thursday. “But we must not take our foot off the gas. Continued vigilance is needed to further reduce all forms of tobacco use among youth. Addressing inequalities remains an essential part of this effort to ensure we leave no one behind.”

Female students consistently reported the most important decline in use, and Hispanic students also reported declines in use of all tobacco products. Authorities said evidence-based strategies, including price increases, media campaigns and smoking ban measures, are more likely to have led to a decline in tobacco consumption.

Among students who reported using tobacco products, e-cigarettes remain essentially the most commonly used tobacco product at 5.9%, but nicotine pouches are actually the second mostly used tobacco product at 1.8%, followed by cigarettes at 1. 4%.

Nicotine pouch use amongst students actually increased, although not by enough to be considered significant, from 1.2% in 2023 to 1.8% in 2024, the CDC said in September.

“Youth use of tobacco products in any form – including e-cigarettes and nicotine pouches – is unsafe,” said Deirdre Lawrence Kittner, director of the CDC’s Office on Smoking and Health, in a press release in September. “It is important that we remain vigilant and committed to public health to ensure all youth can lead healthy, tobacco-free lives.”

Zyn was the most well-liked nicotine pouch brand at 68.7%, in comparison with the second hottest brand On at 14.2%.

Zyn, the oral nicotine pouch brand from Philip Morris Internationalexploded in popularity on social media earlier this 12 months which led to a nationwide shortage. Philip Morris announced plans to accomplish that in July Invest 600 million dollars in response to increased demand in a brand new Zyn production facility in Colorado.

The survey was distributed to 29,861 students from 283 schools from January 22 to May 22.

WASHINGTON – The Supreme Court agreed Tuesday to look at whether the Food and Drug Administration acted unlawfully when it refused to approve flavored electronic cigarettes commonly utilized by teenagers.

The case puts the FDA's role in approving recent nicotine products under scrutiny at a time when the number of recent products is increasing rapidly.

Electronic cigarette manufacturers across the country have filed lawsuits difficult the FDA's decisions.

The FDA won most of those cases, but appealed to the Supreme Court after the U.S. fifth Circuit Court of Appeals ruled in January in favor of two e-cigarette firms searching for approval for his or her products. The appeals court concluded that the FDA had improperly evaluated the businesses' applications, violating a federal law called the Administrative Procedure Act.

The lawsuit was brought by Triton Distribution, a manufacturer of e-liquids for vape pens within the flavors “Signature Series Mom's Pistachio” and “Suicide Bunny Mother's Milk and Cookies”, in addition to by Vapestasia, which has applied for approval of flavors similar to “Iced Pineapple Express” and “Killer Kustard Bluebery”.

Three other appeals by e-cigarette firms that lost in lower courts are also pending before the Supreme Court.

The FDA has repeatedly refused to approve flavored e-cigarettes, saying they pose a health risk by encouraging young people to make use of tobacco, despite the fact that they continue to be widely available. The firms say the FDA erred in arguing that their products could help people quit smoking.

The FDA concluded that the potential advantages of helping adult smokers quit smoking don’t outweigh the potential health risks to young people.

Meanwhile, the consumption of other nicotine-containing products amongst young people has increased.

The FDA recently approved Menthol-flavored e-cigarettes for the primary time. Other e-cigarette products have also been approved.

In the wake of the talk over the potential health risks of vaping, the FDA this month also lifted its ban to sell Juul vape products.

The justices will hear oral arguments and judge the case through the Supreme Court's next term, which begins in October and ends in June 2025.

The Food and Drug Administration on Friday approved the primary menthol-flavored electronic cigarettes for adult smokers, recognizing that flavors in vaping can reduce the harms of traditional tobacco smoking.

The FDA announced that it has approved 4 menthol e-cigarettes from Njoy, the vaping brand recently acquired by the tobacco giant Altriawhich also sells Marlboro cigarettes.

The decision lends latest credibility to the e-cigarette corporations’ long-standing claim that their Products may also help mitigate the consequences of smokingwhich is chargeable for 480,000 deaths annually within the United States attributable to cancer, lung disease and heart disease.

Parent groups and anti-tobacco activists immediately criticized the choice, which got here after years of pressure on regulators to ban menthol and other flavors which will appeal to teenagers taken off the market.

“This decision may mean we will never be able to close the Pandora's box of the youth e-cigarette epidemic,” said Meredith Berkman, co-founder of Parents Against Vaping E-cigarettes. “The FDA has once again failed American families by allowing a predatory industry to acquire its next generation of customers for life – America's children.”

Vaping amongst teens has declined from all-time highs lately. About 10% of highschool students reported using e-cigarettes up to now yr. Of those vapers, 90% used flavors, including menthol.

All previously FDA-approved e-cigarettes contained tobacco, which is just not quite common amongst young vapers.

Njoy is one in all only three corporations to have previously received FDA approval for vaping products. Like those products, the menthol variants come as cartridges which can be inserted right into a reusable device that heats liquid nicotine, turning it into an inhalable aerosol.

According to retail data from Nielsen, Njoy's products accounted for lower than 3% of U.S. e-cigarette sales last yr. Vuse, owned by Reynolds Americanand Juul control about 60% of the market, while lots of of Disposable stamps The rest is to be paid.

Most teens who vape use disposable e-cigarettes, including brands like Elf Barwhich are available in flavors like watermelon and blueberry ice cream.

Altria's data showed that Njoy e-cigarettes helped smokers reduce their exposure to the harmful chemicals in traditional cigarettes, the FDA said. The agency stressed that the products are neither protected nor “FDA-approved” and that nonsmokers shouldn’t use them.

Friday's motion is a component of a broader FDA review designed to bring the multibillion-dollar e-cigarette market under scientific scrutiny after years of regulatory delays. There are currently 1000’s of fruit- and candy-flavored e-cigarettes on the U.S. market that, while technically illegal, are widely available in convenience stores, gas stations and vape shops.

The FDA faced a self-imposed court deadline later this month to finish its years-long review of major e-cigarette brands, including Juul and Vuse.

These brands have been sold within the U.S. for years pending FDA review of their scientific applications. To stay available on the market, corporations must display that their e-cigarettes provide overall health advantages to smokers without being particularly attractive to children.

“Based on our rigorous scientific review, the evidence that adult smokers benefit from completely switching to a less harmful product was sufficient, in this case, to outweigh the risks to youth,” said Matthew Farrelly of the FDA's Center for Tobacco Products.